浸润性宫颈癌与复方口服避孕药。世界卫生组织肿瘤与甾体激素避孕药协作研究
Invasive cervical cancer and combined oral contraceptives. WHO collaborative study of neoplasia and steroid contraceptives.
出版信息
Br Med J (Clin Res Ed). 1985 Mar 30;290(6473):961-5. doi: 10.1136/bmj.290.6473.961.
Abstract
A multicentre, hospital based case-control study is being conducted under the auspices of the World Health Organisation to determine whether steroid contraceptives alter the risk of gynaecological, breast, and hepatic neoplasms. Preliminary results, largely from developing countries, on the relation between combined oral contraceptives and invasive cervical carcinoma showed a relative risk of 1.19 (95% confidence interval 0.99-1.44) in women who had ever used oral contraceptives. The risk increased with duration of use, giving a relative risk of 1.53 after five years. This finding supports a causal interpretation, but it could also be due to incomplete control for confounding sexual variables and other sources of bias.
摘要
在世界卫生组织的支持下，正在开展一项以医院为基础的多中心病例对照研究，以确定甾体类避孕药是否会改变患妇科、乳腺和肝脏肿瘤的风险。主要来自发展中国家的关于复方口服避孕药与浸润性宫颈癌之间关系的初步结果显示，曾经使用过口服避孕药的女性的相对风险为1.19（95%置信区间0.99 - 1.44）。风险随使用时间增加，使用五年后的相对风险为1.53。这一发现支持因果关系的解释，但也可能是由于对混杂的性变量和其他偏倚来源控制不完全所致。
相似文献
1
Invasive cervical cancer and combined oral contraceptives. WHO collaborative study of neoplasia and steroid contraceptives.浸润性宫颈癌与复方口服避孕药。世界卫生组织肿瘤与甾体激素避孕药协作研究
Br Med J (Clin Res Ed). 1985 Mar 30;290(6473):961-5. doi: 10.1136/bmj.290.6473.961.
2
Invasive squamous-cell cervical carcinoma and combined oral contraceptives: results from a multinational study. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.浸润性宫颈鳞状细胞癌与复方口服避孕药：一项多国研究的结果。世界卫生组织肿瘤与甾体避孕药协作研究。
Int J Cancer. 1993 Sep 9;55(2):228-36. doi: 10.1002/ijc.2910550211.
3
Combined oral contraceptives and risk of cervical carcinoma in situ. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.复方口服避孕药与原位宫颈癌风险。世界卫生组织肿瘤与甾体类避孕药协作研究。
Int J Epidemiol. 1995 Feb;24(1):19-26. doi: 10.1093/ije/24.1.19.
4
Invasive cervical cancer and combined oral contraceptives.浸润性宫颈癌与复方口服避孕药
Br Med J (Clin Res Ed). 1985 May 11;290(6479):1433-4. doi: 10.1136/bmj.290.6479.1433-b.
5
Oral contraceptives and invasive adenocarcinomas and adenosquamous carcinomas of the uterine cervix. The World Health Organization Collaborative Study of Neoplasia and Steroid Contraceptives.口服避孕药与子宫颈浸润性腺癌和腺鳞癌。世界卫生组织肿瘤与甾体避孕药协作研究。
Am J Epidemiol. 1996 Aug 1;144(3):281-9. doi: 10.1093/oxfordjournals.aje.a008923.
6
The WHO Collaborative Study of Neoplasia and Steroid Contraceptives: the influence of combined oral contraceptives on risk of neoplasms in developing and developed countries.世界卫生组织肿瘤与甾体避孕药协作研究：复方口服避孕药对发展中国家和发达国家肿瘤风险的影响。
Contraception. 1991 Jun;43(6):695-710. doi: 10.1016/0010-7824(91)90010-d.
7
Oral contraceptives and neoplasia.口服避孕药与肿瘤形成
J Reprod Med. 1984 Jul;29(7 Suppl):524-9.
8
Oral contraceptive use and invasive cervical cancer.口服避孕药的使用与浸润性宫颈癌
Int J Epidemiol. 1990 Jun;19(2):259-63. doi: 10.1093/ije/19.2.259.
9
Oral contraceptives and cancers of the breast and of the female genital tract. Interim results from a case-control study.口服避孕药与乳腺癌和女性生殖道癌。一项病例对照研究的中期结果。
Br J Cancer. 1986 Aug;54(2):311-7. doi: 10.1038/bjc.1986.178.
10
[Oral contraceptives and cervix uteri cancer].[口服避孕药与子宫颈癌]
Tidsskr Nor Laegeforen. 1978 Oct 20;98(29):1422-3.
引用本文的文献
1
Comparison of risk factors for squamous cell and adenocarcinomas of the cervix: a meta-analysis.子宫颈鳞状细胞癌和腺癌危险因素的比较：一项荟萃分析。
Br J Cancer. 2004 May 4;90(9):1787-91. doi: 10.1038/sj.bjc.6601764.
2
Reproductive factors and incidence of breast cancer: an international ecological study.
Soz Praventivmed. 2000;45(6):247-57. doi: 10.1007/BF01591687.
3
Oral contraceptive use and the prognosis of breast cancer.口服避孕药的使用与乳腺癌的预后
Breast Cancer Res Treat. 1994;30(3):283-92. doi: 10.1007/BF00665969.
4
Prognostic value of proliferating cell nuclear antigen and c-erbB-2 compared with conventional histopathological factors in breast cancer.与传统组织病理学因素相比，增殖细胞核抗原和c-erbB-2在乳腺癌中的预后价值。
J Cancer Res Clin Oncol. 1995;121(2):115-22. doi: 10.1007/BF01202223.
5
The relationship between oral contraceptive use, cancer and vascular disease.口服避孕药的使用与癌症及血管疾病之间的关系。
Drug Saf. 1990 Nov-Dec;5(6):436-46. doi: 10.2165/00002018-199005060-00004.
6
Oral contraceptives and human papillomavirus infection in cervical intraepithelial neoplasia.
Arch Gynecol Obstet. 1992;252(1):25-30. doi: 10.1007/BF02389603.
7
Reproductive factors in the etiology of hepatocellular carcinoma. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives.肝细胞癌病因中的生殖因素。世界卫生组织肿瘤与甾体避孕药协作研究。
Cancer Causes Control. 1992 Jan;3(1):37-42. doi: 10.1007/BF00051910.
本文引用的文献
1
Contraceptives and dysplasia: higher rate for pill choosers.避孕药与发育不良：选择服用避孕药的人出现发育不良的比率更高。
Science. 1970 Jul 31;169(3944):497-8. doi: 10.1126/science.169.3944.497.
2
Characteristics of women with dysplasia or carcinoma in situ of the cervix uteri.子宫颈发育异常或原位癌女性的特征。
Br J Cancer. 1980 Sep;42(3):359-69. doi: 10.1038/bjc.1980.246.
3
Viruses and gynecologic cancers: herpesvirus protein (ICP 10/AG-4), a cervical tumor antigen that fulfills the criteria for a marker of carcinogenicity.病毒与妇科癌症：疱疹病毒蛋白（ICP 10/AG-4），一种满足致癌性标志物标准的宫颈肿瘤抗原。
Cancer. 1981 Jul 15;48(2 Suppl):455-71. doi: 10.1002/1097-0142(19810715)48:1+<455::aid-cncr2820481306>3.0.co;2-2.
4
Cigarette smoking and dysplasia and carcinoma in situ of the uterine cervix.吸烟与子宫颈发育异常及原位癌
JAMA. 1983;250(4):499-502.
5
Smoking and carcinoma in situ of the uterine cervix.吸烟与子宫颈原位癌
Am J Public Health. 1983 May;73(5):558-62. doi: 10.2105/ajph.73.5.558.
6
Oral contraceptives and cervical cancer.口服避孕药与宫颈癌
Lancet. 1983 Dec 3;2(8362):1310. doi: 10.1016/s0140-6736(83)91190-x.
7
Oral contraceptives and cancer.口服避孕药与癌症。
Lancet. 1983 Oct 29;2(8357):1018-20.
8
Neoplasia of the cervix uteri and contraception: a possible adverse effect of the pill.子宫颈肿瘤与避孕：避孕药可能的不良影响。
Lancet. 1983 Oct 22;2(8356):930-4. doi: 10.1016/s0140-6736(83)90451-8.
9
Importance of the male factor in cancer of the cervix.男性因素在宫颈癌中的重要性。
Lancet. 1982 Sep 11;2(8298):581-3. doi: 10.1016/s0140-6736(82)90661-4.
10
Relationship of oral contraceptives to cervical carcinogenesis.口服避孕药与宫颈癌发生的关系。
Obstet Gynecol. 1972 Oct;40(4):508-18.
Zotero 插件